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ABSTRACT
Acute leukemia often presents with symptoms due to bone marrow failure. But with atypical presentations, the diagnosis may not be 
straight forward and requires thorough clinical examination followed by carefully selected and interpreted investigations. We present 
a case of acute leukemia in a child who was admitted with pain and swelling of foot. In absence of classical features, leukemia was 
not initially suspected and even on subsequent biopsy, the diagnosis could not be picked up, requiring thorough re evaluation. We have 
hereby made an effort to analyse the pitfalls in this case to help practising clinicians and pathologists who might encounter similar 
scenarios.
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Leukemia is the most common childhood malignancy globally, wherein the overall proportion of leukemia in India ranges from 26.7% to 52.3% of all childhood 
cancers [1]. Though the diagnosis of acute leukemia is not very 
cumbersome with the help of routine investigations, difficulties 
arise when presentation is atypical, mimicking other diseases, as in 
our case. Our patient presented with a bone lesion in the extremity 
suspected to be osteomyelitis. Though osteoarticular symptoms 
are not very rare in acute leukemia, the radiological correlation 
is poor and hence a high index of suspicion is necessary to arrive 
at the diagnosis [2]. As we have noted on retrospective analysis 
of our case, routine and special investigations, unless carefully 
selected and interpreted in the light of possible differential 
diagnoses, can also mislead the clinician and pathologist. This 
results in undue delay in initiation of treatment. We intend 
to throw light on the initial diagnostic pitfalls in this case and 
improve awareness about these interpretative errors.
CASE HISTORY
A 4 year old female child, foreign national, presented to the local 
hospital with low grade fever of 2 weeks. She also had severe 
pain in the left foot making it difficult to bear weight and she 
was reluctant to walk for over a week. Her orthopedician noted 
tense tender swelling above the first metatarsal of left foot. Other 
systems were within normal limits. 
Her haemoglobin level and total leucocyte count at that time 
were 8.8g/dL and 5900/mm3 with C-reactive protein (CRP) 
of 8.13mg/L as noted in the discharge summary. X-ray and 
ultrasonography of left foot revealed cortical erosion at the 
base of first metatarsal. It was coupled with mildly increased 
vascularity and edema of adjacent soft tissue and was reported 
as osteomyelitis (Fig. 1). On subsequent MRI scan also, the 
possibility of infectious etiology, probably tuberculosis was 
suggested. 
She was posted for debridement and curettage from the bone 
lesion; the cheesy material obtained was sent for histopathological 
evaluation. Biopsy report from an outside laboratory service 
suggested a high grade primitive neuroectodermal tumor (PNET) 
/ Ewing’s sarcoma. It was diagnosed based on the presence of 
neoplastic small round cells positive for vimentin, MIC2 (CD99) 
and focally for neuron specific enolase with Ki67 in 70-80% 
cells on immunohistochemistry. CD45, pancytokeratin, desmin, 
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Figure 1: X-ray feet showing lytic lesion in (L) first metatarsal
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synaptophysin and chromogranin were negative. Hence she presented 
to the Oncology department at our centre for further management.
At presentation in our centre, her routine blood counts 
revealed low haemoglobin - 5.7g/dL, total leucocyte count of 
11520/mm3, thrombocytopenia - 37000 platelets/mm3 and CRP 
- 11.08mg/L. Serum calcium level was 10.18 mg/dL and LDH 
was 320 U/L. Peripheral smear revealed alarming 25% large 
atypical cells with blast morphology and bone marrow study was 
advised. Bone marrow study showed 96% blasts (Fig. 2) which 
on flow cytometry expressed CD19, CD20, CD22, CD10, HLA 
DR, CD34, CD38, CD86 and cytoplasmic CD79a suggestive of 
B- acute lymphoblastic leukemia (B-ALL). Subsequently, the 
bone curettage slides were reviewed and immunohistochemistry 
repeated which revealed positivity for CD99, CD20, Tdt and 
PAX5 with Ki 67 index of >90% in the small round cells (Fig.3). 
CD45, CD3 and synaptophysin were negative; hence reported as 
consistent with B-ALL. 
She was initiated on chemotherapy with BFM ALL (Berlin-
Frankfurt-Münster ALL) 2009 Protocol, an International 
collaborative treatment protocol for children and adolescents 
with ALL. The patient tolerated the treatment without major 
complaints and minimal residual disease (MRD) post induction 
was <0.01% of all leucocytes. She is continuing her treatment and 
is presently doing well.
DISCUSSION
Acute lymphoblastic leukemia is the most common paediatric 
haematological malignancy, 80-85% being of precursor B cell 
phenotype [3]. Most of the patients present with consequences of 
bone marrow failure like tiredness, pallor and purpura, fever with 
or without organomegaly and osteoarticular symptoms including 
pain, swelling or functional impairment.
Over 40% patients present with pain in their bones and seek 
orthopaedic help early in the course of the disease. Though 
this is frequently attributed to leukemic cell proliferation in 
marrow producing mass effect, the symptoms and radiographic 
changes often correlate  poorly [2]. A variety of changes 
including osteopenia, lytic/ sclerotic/ mixed lesions, radiolucent 
metaphyseal bands, periosteal reaction, avascular osteonecrosis 
and pathological fractures have been described, though none is 
pathognomonic for leukemia. 
These invite an array of differential diagnoses comprising 
inflammatory lesions like septic arthritis or osteomyelitis [4] as in 
our case as well as tumors like neuroblastoma, Ewing’s sarcoma/
PNET and rhabdomyosarcoma in children [5]. At this stage, a 
biopsy could help in distinction between inflammatory/ infective 
etiologies and malignancy, although ancillary studies like 
immunohistochemistry become mandatory in the latter, owing to 
the small round cell morphology in most of them.
In our case, in the context of clinical and radiological suspicion 
of osteomyelitis, initial bone biopsy report of malignancy came 
as a surprise. Though morphology confirmed a small round 
cell tumour, exact diagnosis of the entity could not be made. It 
highlights the need for clinical correlation as well as an extensive 
panel of immunohistochemical markers with awareness of 
variable antigen expression profiles in this confusing group of 
tumors. Here, the combination of CD45 negativity with MIC2 
positivity might have misled the reporting pathologists making 
them drift away from diagnosis of a hematopoietic neoplasm. 
Although CD45 is often used to exclude hematopoietic origin 
in undifferentiated tumors, it is important to remember that some 
cases of B-ALL/B-LBL (B-lymphoblastic lymphoma), acute 
myeloid leukemia (AML) cases of erythroid and megakaryocytic 
lineages as well as many mature hematopoietic tumors such as 
anaplastic large cell lymphomas, classical Hodgkin lymphomas and 
neoplasms with plasmacytic differentiation lack CD45 expression. 
Hence, in cases of suspected B-ALL, TdT (preferably) or 
CD34 have been advocated to confirm the immaturity of cells 
and PAX-5 (preferably), CD79a or CD22 with CD10 to ascertain 
the lineage. CD20 used as common screening marker for B cell 
lineage is often negative or weak in B-ALL and CD19 lacks 
reliability on immunohistochemistry [6]. Olsen et al specifically 
observed that positive Tdt in ALL might help in distinction from 
Ewing’s sarcoma as both tumors can be CD45 negative and 
CD99 positive. Hence judicious use of markers and their careful 
Figure 2: Bone marrow aspirate showing lymphoblasts (Leishman 
stain,1000x)
Figure 3: Immunohistochemistry on bone biopsy showing tumor 
cells positive for CD99, PAX5, TdT and Ki 67 (400x)
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interpretation are absolutely essential for arriving at the right 
diagnosis.
Within a cohort of 493 cases diagnosed over 22 years, Kebudi 
R et al reported 5 cases of aggressive lymphoma/leukemia 
presenting as solitary bone tumor. All the 5 cases were initially 
diagnosed erroneously as Ewing’s sarcoma with a limited 
immunohistochemistry panel [7]. Ozdemirli et al also reported 
four cases of B-LBL presenting with localized intraosseous 
mass mimicking Ewing’s sarcoma clinically and histologically 
[8]. Thus, distinction between these entities can be difficult 
especially on small or crushed biopsy material. Hence complete 
immunophenotyping and wherever necessary, molecular studies 
are critical as the clinical behaviour and treatment are markedly 
different [9].
Bone changes in ALL are probably underreported as patients 
are subjected to imaging studies only in the presence of symptoms. 
Sinigaglia et al studied musculoskeletal manifestations of pediatric 
acute leukemias in 122 patients and noted that clinical localisation 
was mostly in extremities. Total 40.2% had radiographic changes 
at presentation and osteolysis was the commoner pattern (13.1%) 
though the overall prevalence of osteolytic lesions in ALL is low 
[4]. Most of these lesions localise in metaphysis of long bones, 
flat/ small bones may also be involved. 
Though the pathogenesis is yet to be unravelled fully, 
osteoclast activation by parathyroid related protein (PTHrP) or 
the receptor activator of nuclear factor-kappa B ligand (RANKL) 
secreted by ALL cells is proposed. Mediators like transforming 
growth factor-beta, macrophage inflammatory protein-1a (MIP-
1a) and inflammatory cytokines including interleukin (IL)-
6, IL-3 and tumour necrosis factor have also been implicated 
[10]. The nutrients released from bones in turn, support tumor 
cell proliferation. Hence, osteoclast targeting agents and 
monoclonal antibodies against these mediators are prospective 
treatment options in these cases. However, the overall prognostic 
significance of osteolytic bone disease is still not clear [2]. 
CONCLUSION
In patients with atypical presentations, a high index of suspicion 
is necessary for early diagnosis of acute leukemia. Detailed 
history and examination along with preliminary hematological 
and biochemical investigations would give us useful clues. 
In the event of suspicious skeletal changes on imaging, as in 
our case, bone biopsy with carefully selected and interpreted 
immunohistochemistry panel and where indicated, molecular 
studies become essential to ensure appropriate therapy and 
predict prognosis.
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